Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-04-26

Clinical Trial Update: Post Marketing Surveillance Study To Observe Safety And Efficacy Of Sutene

View source ↗

Summary

A post-marketing surveillance study evaluating the safety and efficacy of Sutene in patients with gastrointestinal stromal tumors; the study status is completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sutene

Snippet

Sponsor: Pfizer | Conditions: Gastrointestinal Stromal Tumors | Status: COMPLETED | Results posted: 2016-04-26